
Serum for near atopical
skin
Vitamin C 10 %
Ginkgo Biloba
Green tea extract
Vitis vinifera extract
Vitamin C and atopy
Status of Vitamin C in
patients with atopic dermatitis
Patients with atopic dermatitis would have lower levels
of Vitamin C compared to healthy subjects. A first study
performed by Leveque and al showed that Ascorbic Acid
levels in the dermis of patients with atopic dermatitis
were inferior to those of healthy volunteers. This phenomenon
could be explained by the consumption of Vitamin C who
scavenges the reactive oxygen species involved during
the inflammatory process. The authors concluded that
the evaluation of the Ascorbic Acid levels could be
useful to characterize inflammatory skin diseases. This
decline could also be due to Vitamin C who serves to
the regeneration of Vitamin E or by its antagonism with
histamine.
In another trial whose aim was to examine the food intake
of patients with atopic dermatitis, Barth and al attributed
this decline to the fact that patients with atopic dermatitis
would consume less fruits than asymptomatic persons.
They observed that between 16 and 58 % of the symptomatic
patients had a significantly lower consumption of fruits
compared to controls thus leading to an inferior consumption
of Vitamin C.
Effects of a supplementation
of Vitamin C
In a recent study, Hoppu and
al showed that Vitamin C in breast milk could reduce
the risks of atopy in the infant. The patients of this
study were mothers with atopy and their infant aged
of one month. Food intake of the mothers and their milk
were analysed. The investigators concluded that Vitamin
C concentration in the milk was dependent of the quantity
consumed by the mother. On the other hand, the risk
of atopy was weaker in infants whose mother had a higher
concentration of Vitamin C in their milk. The group
who was more likely to develop Vitamin C deficiencies
was the same as the one with alimentary allergies.This
study demonstrated that breastfeeding rich in Vitamin
C could reduce the probability to develop atopy in high
risk infants.
In a study made by Soutar and al, evidence was provided
that a poor consumption in antioxidant and in consequence
in Vitamin C increased the prevalence of atopy.
In their study on the increased oxidative stress in
childhood atopic dermatitis, Omata and al came to the
conclusion that the use of ant oxidative agents might
be a potentially useful strategy for the treatment of
atopic dermatitis.
Vitamin C in the
restoration of the barrier effect
With the study performed by Ponec and al on different
reconstructed epidermis, the authors came to the conclusion
that the composition and the ceramide profile in the
cell cultures normalized in the presence of Vitamin
C who also improved the epidermal morphology and the
stratum corneum ultrastructure. In addition, Vitamin
C supplementation leads to a marked improvement of the
stratum corneum lipid organization. The primary role
of Vitamin C could most probably be ascribed to Vitamin-C
induced facilitation of hydroxylation of sphingoid bases
and of fatty acids and not to its anti-oxidative activity
in preventing the formation of free oxygen radicals
or lipid peroxides. The finding that only skin equivalents
formed in Vitamin-C supplemented medium are capable
of synthesizing sufficient amounts of all glucosylceramide
classes indicates the crucial role of Vitamin-C in the
regulation of the synthesis of competent barrier lipids.
Clinical trial
Efficacy
and tolerance of CATOPIX-C clinically assessed
Prospective study performed
by Pr P. Humbert at the University
of Besançon, September 2005:
• Double blind study Catopix-C
versus excipient • Patients with atopic
eczema from light to moderate • Two pulverisations
twice a day • Measurement of SCORAD, localized
SCORAD, transepidermal water loss, hydratation index,
dryness index and ph • Evaluation of the
well-being sensation and the tolerance |
Result
Evaluation of the localized SCORAD:
Regression of eczema lesions of 34 %
|
|
Evaluation
of the barriereffect:
decrease of 20 % of the T.W.L
|
 |
|
|
| Evaluation
of the localized SCORAD:
Regression of eczema lesions of 34 %
|
|
|
Evaluation of the tolerance:
using a visual analogue scale ranging from 0 to 10,
100 % of the patients reported 10 for CATOPIX-C indicating
the excellent tolerance of the product ad the well-being
sensation generated.
Product description
Composition
CATOPIX-C has the following active components:
• Double blind study Catopix-C
versus excipient • Patients with atopic
eczema from light to moderate • Two pulverisations
twice a day • Measurement of SCORAD, localized
SCORAD, transepidermal water loss, hydratation index,
dryness index and ph • Evaluation of the
well-being sensation and the tolerance |
Mode of action
The efficacy of CATOPIX-C is based on two additive effects:
| 1. |
It
restores the barrier effect of the skin by supplementing
the dermis in Vitamin C.
The latter leads to a marked improvement of the
SC lipid organization: composition and ceramide
profile in reconstructed epidermis are normalized
in the presence of Vitamin C. |
| 2.
|
It prevents the
oxidative stress and reduces the inflammatory events
who are characteristic of the atopic skin. |
The anti oxidizing power of the Vitamin C is reinforced
with Gingko Biloba extract.
Instructions for use
Apply CATOPIX-C twice daily
to sensitive areas. The product is easily absorbed into
the skin. In order to avoid staining, wait a few minutes,
leaving a feeling of comfort and well-being.
Warning
Do not allow the product to come
into the contact with the eyes. In the event of accidental
contact, rinse the eyes thoroughly with water.
Bibliography
• Leveque N, Robin S, Muret
P, Mac-Mary S, Makki S, Humbert P. High iron and low
ascorbic acid concentrations in the dermis of atopic
dermatitis patients. Dermatology. 2003; 207(3): 261-4.
• Hoppu U, Kalliomaki M, Isolauri E. Maternal
diet rich in saturated fat during breastfeeding is associated
with atopic sensitization of the infant. Eur J Clin
Nutr. 2000 Sep; 54(9): 702-5.
• Omata N, Tsukahara H, Ito S, Ohshima Y, Yasutomi
M, Yamada A, Jiang M, Hiraoka M, Nambu M, Deguchi Y,
Mayumi M. Increased oxidative stress in childhood atopic
patients. Life Sciences. 2001 Jun; 69(2): 223-228.
• Barth GA, Weigl L, Boeing H, Disch R, Borelli
S. Food intake of patients with atopic dermatitis. Eur
J Dermatol. 2001 Jun; 11(3): 199-202.
• Vega C. Higher Concentration of Vitamin C in
Breast Milk Linked to Lower Rate of Infant Atopy. Eur
J Clin Nutr. 2005 Aug; 59: 123-128.
• Ponec M, Weerheim A, Kempenaar J, Mulder A,
Gooris GS, Bouwstra J, Mommaas AM. The formation of
competent barrier lipids in reconstructed human epidermis
requires the presence of vitamin C. J Invest Dermatol.
1997 Sep; 109(3): 348-55.
• Hoppu U, Rinne M, Salo-Vaananen P, Lampi A-M,
Piironen V, Isolauri E. Vitamin C in breast milk may
reduce the risk of atopy in the infant. Eur J Clin Nutr.
2005 ; 59: 123-128.
 |